AAAAAA
Results:
1-18
|
Results: 18
Authors:
Virolle, T
Adamson, ED
Baron, V
Birle, D
Mercola, D
Mustelin, T
de Belle, I
Citation: T. Virolle et al., The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling, NAT CELL BI, 3(12), 2001, pp. 1124-1128
Authors:
Calogero, A
Arcella, A
De Gregorio, G
Porcellini, A
Mercola, D
Liu, CT
Lombari, V
Zani, M
Giannini, G
Gagliardi, FM
Caruso, R
Gulino, A
Frati, L
Ragona, G
Citation: A. Calogero et al., The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas, CLIN CANC R, 7(9), 2001, pp. 2788-2796
Authors:
Parra, E
Mustelin, T
Dohlsten, M
Mercola, D
Citation: E. Parra et al., Identification of a CD28 response element in the CD40 ligand promoter, J IMMUNOL, 166(4), 2001, pp. 2437-2443
Authors:
Potapova, O
Basu, S
Mercola, D
Holbrook, NJ
Citation: O. Potapova et al., Protective role for c-Jun in the cellular response to DNA damage, J BIOL CHEM, 276(30), 2001, pp. 28546-28553
Authors:
Mercola, D
Citation: D. Mercola, Combined antisense therapy and chemotherapy in animal models, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, 2001, pp. 687-707
Authors:
Gjerset, R
Haghighi, A
Lebedeva, S
Mercola, D
Citation: R. Gjerset et al., Gene therapy approaches to sensitization of human prostate carcinoma to cisplatin by adenoviral expression of p53 and by antisense Jun kinase oligonucleotide methods, METH MOL B, 175, 2001, pp. 495-520
Authors:
de Belle, I
Mercola, D
Adamson, ED
Citation: I. De Belle et al., Method for cloning in vivo targets of the Egr-1 transcription factor, BIOTECHNIQU, 29(1), 2000, pp. 162-169
Authors:
Bost, F
McKay, R
Dean, NM
Potapova, O
Mercola, D
Citation: F. Bost et al., Antisense methods for discrimination of phenotypic properties of closely related gene products: Jun kinase family, METH ENZYM, 314, 2000, pp. 342-362
Authors:
Gjerset, RA
Mercola, D
Citation: Ra. Gjerset et D. Mercola, Sensitization of tumors to chemotherapy through gene therapy, ADV EXP MED, 465, 2000, pp. 273-291
Authors:
Potapova, O
Gorospe, M
Bost, F
Dean, NM
Gaarde, WA
Mercola, D
Holbrook, NJ
Citation: O. Potapova et al., c-Jun N-terminal kinase is essential for growth of human T98G glioblastomacells, J BIOL CHEM, 275(32), 2000, pp. 24767-24775
Authors:
Liu, CT
Yao, J
Mercola, D
Adamson, E
Citation: Ct. Liu et al., The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251, J BIOL CHEM, 275(27), 2000, pp. 20315-20323
Authors:
Sobol, RE
Shawler, DL
Carson, C
Van Beveren, C
Mercola, D
Fakhrai, H
Garrett, MA
Barone, R
Goldfarb, P
Bartholomew, RM
Brostoff, S
Carlo, DJ
Royston, I
Gold, DP
Citation: Re. Sobol et al., Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: A phase I study, CLIN CANC R, 5(9), 1999, pp. 2359-2365
Authors:
Gjerset, RA
Lebedeva, S
Haghighi, A
Turla, ST
Mercola, D
Citation: Ra. Gjerset et al., Inhibition of the Jun kinase pathway blocks DNA repair, enhances p53-mediated apoptosis and promotes gene amplification, CELL GROWTH, 10(8), 1999, pp. 545-554
Authors:
de Belle, I
Huang, RP
Fan, Y
Liu, CT
Mercola, D
Adamson, ED
Citation: I. De Belle et al., P53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis, ONCOGENE, 18(24), 1999, pp. 3633-3642
Authors:
Bost, F
McKay, R
Bost, M
Potapova, O
Dean, NM
Mercola, D
Citation: F. Bost et al., The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells, MOL CELL B, 19(3), 1999, pp. 1938-1949
Authors:
Liu, CT
Yao, J
de Belle, I
Huang, RP
Adamson, E
Mercola, D
Citation: Ct. Liu et al., The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta(1), fibronectin, and plasminogen activator inhibitor-1, J BIOL CHEM, 274(7), 1999, pp. 4400-4411
Authors:
Hayakawa, J
Ohmichi, M
Kurachi, H
Ikegami, H
Kimura, A
Matsuoka, T
Jikihara, H
Mercola, D
Murata, Y
Citation: J. Hayakawa et al., Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line, J BIOL CHEM, 274(44), 1999, pp. 31648-31654
Differential effect of retinoic acid on growth regulation by phorbol esterin human cancer cell lines
Authors:
Agadir, A
Chen, GQ
Bost, F
Li, Y
Mercola, D
Zhang, XK
Citation: A. Agadir et al., Differential effect of retinoic acid on growth regulation by phorbol esterin human cancer cell lines, J BIOL CHEM, 274(42), 1999, pp. 29779-29785
Risultati:
1-18
|